logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
P

Paul Grootendorst

university of toronto

31H-index
196Paper Count
5.4KCitation Count
Published Papers 44
Publication Date
logo
The economics of community pharmacy in Canada. Part 2: A synthesis of the evidence on competitive strategies
errCANADIAN PHARMACISTS JOURNAL
IF1.7
err2026-06-01
err0
PREAI
errPukhov, Olexiy; Hoagland, Alex; Grootendorst, Paul
errShare
errSave
The economics of community pharmacy in Canada. Part 1: Overview and empirical analysis of community pharmacy strategies in Ontario
errCANADIAN PHARMACISTS JOURNAL
IF1.7
err2026-06-01
err0
PREAI
errPukhov, Olexiy; Hoagland, Alex; Grootendorst, Paul
errShare
errSave
The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose
errOsteoporosis International
IF5.4
err2025-09-04
err0
PREAI
errNatalia Konstantelos; Sandra Kim; Angela M. Cheung; Andrea M. Burden; Paul Grootendorst; Suzanne M. Cadarette
errShare
errSave
Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries
errBIODRUGS
IF6.9
err2025-02-25
err0
PREAI
errTam, Alexander C. T.; Badesha, Jasleen; Guh, Daphne P.; Bansback, Nick; Peter, Kevin K.; Hollis, Aidan; Grootendorst, Paul; Bae, Sang-Cheol; Anis, Aslam H.; Zhang, Wei
errShare
errSave
The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis
errHEALTH POLICY
IF3.4
err2024-06-01
err0
errOAAI
errZhang, Wei; Guh, Daphne P.; Grootendorst, Paul; Hollis, Aidan; Anis, Aslam H.
errShare
errSave
The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2024-05-26
err0
errOAAI
errZhang, Wei; Sun, Huiying; Guh, Daphne P.; Grootendorst, Paul; Hollis, Aidan; Anis, Aslam H.
errShare
errSave
Association between non-medical cannabis legalization and alcohol sales: Quasi-experimental evidence from Canada
errDRUG AND ALCOHOL DEPENDENCE
IF3.6
err2024-04-01
err2
errOAAI
errMital, Shweta; Bishop, Lisa; Bugden, Shawn; Grootendorst, Paul; V. Nguyen, Hai
errShare
errSave
Changes in Medical Cannabis Use After Recreational Cannabis Legalization in Canada
errCANNABIS AND CANNABINOID RESEARCH
IF2.7
err2024-02-01
err2
PREAI
errNguyen, Hai V.; Grootendorst, Paul; Mital, Shweta; Bishop, Lisa; McGinty, Emma E.
errShare
errSave
Overview of the global vaccine ecosystem
errEXPERT REVIEW OF VACCINES
IF4.8
err2023-09-04
err2
errOAAI
errMoradpour, Javad; Chit, Ayman; Besada-Lombana, Sandra; Grootendorst, Paul
errShare
errSave
Implementation of the appointment-based model in community pharmacies: An analysis of refills and adherence
errRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY
IF2.8
err2023-09-01
err2
errOAAI
errLin, Qiqi; Mathers, Annalise; Tilli, Tiana; Baker, Jen; Bhaidani, Saleema; Grootendorst, Paul; Cadarette, Suzanne M.; Dolovich, Lisa
errShare
errSave
Modeling Tiered Pricing Frameworks: A Simulation Approach
errVALUE IN HEALTH
IF6
err2023-03-01
err2
errOAAI
errMoradpour, Javad; Zhang, Wei; Grootendorst, Paul; Anis, Aslam H.; Hollis, Aidan
errShare
errSave
The effect of patented drug price on the share of new medicines across OECD countries
errHEALTH POLICY
IF3.4
err2022-08-01
err5
errOAAI
errSpicer, Oliver; Grootendorst, Paul
errShare
errSave
Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review
errOSTEOPOROSIS INTERNATIONAL
IF5.4
err2022-05-17
err7
errOAAI
errKonstantelos, N.; Rzepka, A. M.; Burden, A. M.; Cheung, A. M.; Kim, S.; Grootendorst, P.; Cadarette, S. M.
errShare
errSave
The Impact of Tiered-Pricing Framework on Generic Entry in Canada
errINTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT
IF5.1
err2020-11-16
err6
errOAAI
errZhang, Wei; Sun, Huiying; Guh, Daphne P.; Lynd, Larry D.; Hollis, Aidan; Grootendorst, Paul; Anis, Aslam H.
errShare
errSave
The health impact of delaying direct-acting antiviral treatment for chronic hepatitis C: A decision-analytic approach
errLIVER INTERNATIONAL
IF5.2
err2019-09-25
err8
PREAI
errErman, Aysegul; Wong, William W. L.; Feld, Jordan J.; Grootendorst, Paul; Krahn, Murray D.
errShare
errSave
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
errORPHANET JOURNAL OF RARE DISEASES
IF3.5
err2019-01-10
err75
errOAAI
errJayasundara, Kavisha; Hollis, Aidan; Krahn, Murray; Mamdani, Muhammad; Hoch, Jeffrey S.; Grootendorst, Paul
errShare
errSave
Intellectual Property Protection and Drug Plan Coverage: Evidence From Ontario
errINTERNATIONAL JOURNAL OF HEALTH SERVICES
IF3.1
err2018-07-24
err2
errOAAI
errGrootendorst, Paul; Shim, Minsup; Falconi, Adam; Robinson, Tyler; Lexchin, Joel
errShare
errSave
The case for an essential medicines list for Canada
errCANADIAN MEDICAL ASSOCIATION JOURNAL
IF11.3
err2016-06-13
err10
errOAAI
errEom, Gina; Grootendorst, Paul; Duffin, Jacalyn
errShare
errSave
Economic evaluation of vaccines in Canada: A systematic review
errHUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
err2016-02-18
err8
errOAAI
errChit, Ayman; Lee, Jason K. H.; Shim, Minsup; Van Hai Nguyen; Grootendorst, Paul; Wu, Jianhong; Van Exan, Robert; Langley, Joanne M.
errShare
errSave
Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency Departments
errANNALS OF EMERGENCY MEDICINE
IF5
err2015-11-01
err12
PREAI
errBoutis, Kathy; von Keyserlingk, Camilla; Willan, Andrew; Narayanan, Unni G.; Brison, Robert; Grootendorst, Paul; Plint, Amy C.; Parker, Melissa; Goeree, Ron
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
George A. Wells
H-index: 164 · Papers: 1.3K
J
Jeremy Grimshaw
H-index: 150 · Papers: 1.1K
D
David W. Johnson
H-index: 134 · Papers: 2.1K
S
Sebastian Schneeweiß
H-index: 113 · Papers: 806
A
Allison McGeer
H-index: 113 · Papers: 1.1K
View more